Skip to content

Nutritional Status, Muscle Wasting and Fraility in Intensive Care Patients

The Association Between Nutritional Status and Muscle Wasting and Fraility in Intensive Care Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04709198
Enrollment
44
Registered
2021-01-14
Start date
2020-10-20
Completion date
2022-06-20
Last updated
2022-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Nutritional Disorder

Brief summary

The risk of muscle wasting is high in the intensive care unit patients during the treatment process and this condition is associated with adverse clinical outcomes. The etiology of muscle wasting is multifactorial and medical nutrition therapy plays a key role in muscle wasting treatment and prevention. The aim of this study is assesing the malnutrition and fraility, anthropometric measurements, and muscle mass by ultrasound at the first admission to the intensive care unit and to determine the nutritional factors affecting clinical outcomes. In addition, it is planned to determine the risk factors affecting the change of anthropometric measurements and muscle wasting in the first week during the intensive care unit.

Detailed description

A nutrition-focused physical examination is an integral component in the assessment of critically ill patients. Malnutrition, muscle wasting, and frailty are multidimensional clinical conditions in critically ill patients and are associated with adverse outcomes. Although malnutrition, muscle wasting and frailty are linked, the exact relation between them is unsure. As a result of evaluating these conditions together, it is planned to develop new treatment strategies and to improve the clinical results of patients by determining the relationship between medical nutrition therapy.

Interventions

None listed

Sponsors

Karadeniz Technical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years

Inclusion criteria

* Age ≥45 years and ≤80 years, male or female * Expected ICU stay of seven days or longer * Written informed consent or requirements of local/national ethical committee

Exclusion criteria

* Pregnancy or breastfeeding * Neuromuscular conditions (e.g., multiple sclerosis, muscular dystrophy, spinal cord injury, Guillain-Barre syndrome) * Terminal cancer * Dialysis dependent chronic renal failure * Intoxication * Burn injury * A cognitive impairment prior to the acute illness that is associated with admission to ICU that would impair capacity to follow verbal instructions * Concurrent enrolment in a nutrition-related interventional study at the time of screening

Design outcomes

Primary

MeasureTime frameDescription
Changes in muscle cross-sectional areaBaseline and 7 daysRectus femoris muscle cross-sectional area will be evaluated by ultrasound.
Changes in anthropometric measurementsBaseline and 7 daysTriceps skinfold thickness will be measured by caliper.

Secondary

MeasureTime frameDescription
Duration of mechanical ventilationTime of admission to the ICU until the time of discharge from the intensive care unit, up to 1 yearDuration of mechanical ventilation in survivors and non survivors
Mortality rateTime of admission to the ICU until the time of discharge from the intensive care unit, up to 1 yearICU mortality

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026